Calcium and phosphorus control in patients undergoing hemodialysis: from the view-points of activities of daily living.
To determine the compliance with the JSDT guidelines and activities of daily living (ADLs), phosphorus levels, calcium levels and Barthel index of patients under maintenance hemodialysis therapy in Shinrakuen hospital at December 2005 were evaluated. Of 369 patients, 28.7 % were controlled in the range of JSDT guidelines both phosphorus and calcium. Administration of sevelamer hydrochloride were low both in number of patients and also of using dose. Barthel index were higher in the patients with high phosphorus levels and low calcium level. Patients mortality at February 2007 was highest in the group of low phosphorus and high calcium levels in which the ADLs were the lowest. Concerned about vascular complication, patients in the group with target level or higher level of calcium and phosphorus were frequently noted.
Osawa
Yutaka
Y
Kidney Center, Niigata Rinko Hospital, Momoyama-cho, Niigata City, Japan. osw13nephrology@yahoo.co.jp
D000203:Activities of Daily Living; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002118:Calcium / Q000097:blood*; D002614:Chelating Agents / Q000008:administration & dosage; D005260:Female; D019983:Guideline Adherence; D006761:Hospitals; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000209:etiology / Q000628:therapy; D007564:Japan; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010758:Phosphorus / Q000097:blood*; D011073:Polyamines / Q000008:administration & dosage; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D012189:Retrospective Studies; D012307:Risk Factors; D000069603:Sevelamer; D012955:Societies, Medical; D015996:Survival Rate
D002614:Chelating Agents; D011073:Polyamines; D010758:Phosphorus; D000069603:Sevelamer; D002118:Calcium